Skip to content
lifestyle.independent.mk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
BriaCell Therapeutics Corp.
BriaCell Phase 3 Metastatic Breast Cancer Trial Expands to MSK
September 8, 2026
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
August 24, 2026
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
August 5, 2026
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
May 26, 2026
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
May 24, 2026
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
May 24, 2026
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
May 23, 2026
BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 23, 2026
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
May 23, 2026
BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 22, 2026
1
2
Next Page
→